EDGAR Filing Documents for 9999999995-13-001026

Form EFFECT - Notice of Effectiveness:

SEC Accession No. 9999999995-13-001026

Accepted

2013-04-17 00:15:13

Documents

Effectiveness Date

2013-04-16

Registration Form

F-1

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	EFFECT
1		primary_doc.xml	EFFECT	599
	Complete submission text file	9999999995-13-001026.txt		1705

Mailing Address C/O MARK COHEN, CHAIRMAN, PEARL COHEN 1500 BROADWAY, 12TH FLOOR NEW YORK NY 10036

Business Address 53 DAVIES STREET LONDON X0 W1K 5JH 646-878-0804

Morria Biopharmaceuticals PLC (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: EFFECT | Act: 33 | File No.: 333-187826 | Film No.: 13765449
SIC: 2834 Pharmaceutical Preparations